| ORIGINAL ARTICLE |
|
| Ahead of Print |
|
|
Is programmed death-ligand 1 of prognostic significance in triple-negative female mammary carcinoma?
Amal Mostafa Sanad1, Wael Shawky Ibrahim2, Iman Mohamed Ezzo3, Rania Mohamed Sabry2
1 Department of Pathology, Faculty of Medicine, Tanta Cancer Center, Tanta University, Tanta, Egypt
2 Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt
3 Department of Pathology, Tanta Cancer Center, Tanta University, Tanta, Egypt
Correspondence Address:
Rania Mohamed Sabry,
Department of Pathology, Faculty of Medicine, Cairo University, Cairo
Egypt
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/jmau.jmau_77_21
|
|
|
Introduction: The most widespread female malignancy is breast cancer (BC), considerable percentage of patients with triple-negative BC (TNBC) experience rapid progression, recurrence, and metastasis. BC has not historically been treated as an immunogenic cancer. Nonetheless, several researchers have started to concentrate on immunotherapy. Aim: The aim of the study is to investigate the immunohistochemical (IHC) expression of programmed death-ligand 1 (PD-L1) by stromal tumor-infiltrating lymphocytes (TILs) and tumor cells (TC) in female (TNBC) and to correlate with pathological features of such tumors, particularly those determine biologic behavior, such as the grade and stage the overall survival. Methodology: This is a retrospective study which includes 49 paraffin-embedded tumor tissue sections which were collected from breast surgery specimens either radical or conservative of female patients with TNBC. The samples were analyzed immunohistochemically for PD-L1 expression. Results: There were statistically significant relations among TC PD-L1 expression and TILs PD-L1 expression as well as relations among TILs PD-L1 expression with histologic grade, stromal TILs, and Ki-67 were statistically significant. Correlations between TC PD-L1 expression and N stage, histologic grade, and anatomic stage were statistically significant. Improved survival was detected within TILs PD-L1-positive cases; however, the correlation between the overall survival and PD-L1 expression in both TCs and stromal TIL was not statistically significant. Conclusion: PD-L1 expressed in tumors with poor prognostic features such as the high grade, advanced T stage, and high Ki-67 index, TILs PD-L1-positive cases experienced improved survival supporting its prognostic significance. However, the correlation with overall survival was not statistically significant.
|
|
|
|
|
|
|
Search Pubmed for